Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non Operating Investment Income (2020 - 2023)

Historic Non Operating Investment Income for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Q4 2023 value amounting to -$69000.0.

  • Insight Molecular Diagnostics' Non Operating Investment Income fell 59285.71% to -$69000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$61000.0, marking a year-over-year increase of 8704.88%. This contributed to the annual value of -$61000.0 for FY2023, which is 8704.88% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Non Operating Investment Income of -$69000.0 as of Q4 2023, which was down 59285.71% from -$89000.0 recorded in Q3 2023.
  • Insight Molecular Diagnostics' 5-year Non Operating Investment Income high stood at $315000.0 for Q4 2020, and its period low was -$330000.0 during Q1 2022.
  • For the 4-year period, Insight Molecular Diagnostics' Non Operating Investment Income averaged around -$312.5, with its median value being -$7000.0 (2021).
  • Within the past 5 years, the most significant YoY rise in Insight Molecular Diagnostics' Non Operating Investment Income was 98125.0% (2021), while the steepest drop was 79000.0% (2021).
  • Quarter analysis of 4 years shows Insight Molecular Diagnostics' Non Operating Investment Income stood at $315000.0 in 2020, then plummeted by 106.03% to -$19000.0 in 2021, then soared by 173.68% to $14000.0 in 2022, then plummeted by 592.86% to -$69000.0 in 2023.
  • Its last three reported values are -$69000.0 in Q4 2023, -$89000.0 for Q3 2023, and -$24000.0 during Q2 2023.